Register Login

IDEXX LABORATORIES INC /DE (IDXX)

SymbolIDXX
NameIDEXX LABORATORIES INC /DE
SectorHEALTH CARE
RegionNorth America
IndustryIn Vitro & In Vivo Diagnostic Substances
AddressONE IDEXX DRIVE, WESTBROOK, ME 04092-2041
Telephone2075560300
Fax—
Email—
Websitehttps://www.idexx.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0000874716
Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Additional info from NASDAQ:
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

2026-08-11 11:00

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

Read more
2026-08-04 10:30

IDEXX Laboratories Announces Second Quarter Results

Read more
2026-08-03 21:00

Director HOOLEY JOSEPH L 🟢 acquired 49 shares of IDEXX LABORATORIES INC /DE (IDXX) at $558.80 Transaction Date: Jul 30, 2026 | Filing ID: 000117

Read more
2026-07-01 20:00

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Read more
2026-06-02 21:00

FENNELL GEORGE 🟡 adjusted position in 284 shares (1 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $566.79 Transaction Date: Jun 01, 2026 | Filing ID: 000114

Read more
2026-06-01 17:00

New Form SD - IDEXX LABORATORIES INC /DE <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0000874716-26-000112 <b>Size:</b> 142 KB

Read more
2026-05-26 11:00

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Read more
2026-05-20 22:30

📋 Margaret Anne Szostak (Director) plans to sell 1K shares of IDEXX Laboratories, Inc. (at $553.58 each, total $744K) Filed: May 20, 2026 | ID: 000299

Read more
2026-05-19 11:00

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Read more
2026-05-15 20:00

(99% Neutral) IDEXX LABORATORIES INC /DE (IDXX) Announces Regulatory Update

Read more